Insulin analog glargine may up cancer risk
Monday, July 6, 2009 - 16:49
in Health & Medicine
COLOGNE, Germany, July 6 (UPI) -- German medical researchers say they've determined diabetics who use the long-acting insulin analog glargine might face an increased risk of cancer.